Asterias Biotherapeutics to Present AST-OPC1 Program Update at the Upcoming American Society for Neural Therapy and Repair Conference

NEXT STORY
INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome
PREV STORY
AnaptysBio To Participate in Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Medigus’ MUSE System Continues to Gain Clinical Adoption in the U.S. and Europe, With Number of Procedures Up Three-Fold Over Same Period Last Year

- Top gastroenterologists showcase the benefits of using the MUSE system for transoral fundoplication, ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech withdraws a patent application

FIT Biotech Oy                                                                                                            Company release 13.9.2018 klo 3:45 PM EET   FIT Biotech withdraws ...

author_avatar
NASDAQ Market News

ChemoCentryx Announces Publication in The New England Journal of Medicine of Results of the Pivotal Phase III ADVOCATE Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis

author_avatar
NASDAQ Market News